Sections View Full Chapter Figures Tables Videos Annotate Full Chapter Figures Tables Videos Supplementary Content + • Acute hepatic injury causes sudden loss in hepatocytes due to toxins, ischemia, or inflammatory reaction to liver• Fulminant hepatic failure defined as onset of encephalopathy within 8 weeks (9-24 weeks for subfulminant) after onset of acute hepatocellular injury• Etiologies include: -Hepatitis viruses-Cytomegalovirus (CMV)-Epstein-Barr virus (EBV)-Varicella-Herpesvirus-Toxins (acetaminophen, isoniazid most common)-Ischemia-Fatty liver of pregnancy-Reye syndrome-Wilson disease-Lymphoma-Hereditary metabolic disorders +++ Epidemiology + • 2000 cases of fulminant or subfulminant hepatic failure annually in United States with 80% mortality +++ Symptoms and Signs + • Jaundice• Right upper quadrant pain• Bleeding• Encephalopathy• Hypotension• Sepsis• Renal failure• Uncal herniation• Corneal rings +++ Laboratory Findings + • Hyperbilirubinemia• Elevated transaminases• Prolonged prothrombin time (PT)• Elevated creatinine +++ Imaging Findings + • Head CT can show cerebral edema + • History of chronic liver disorder• Family history of liver failure (eg, Wilson disease)• Exposure to toxins or drugs• Rapidity of encephalopathy onset + • History and physical exam• Serum antibodies for hepatitis viruses, CMV, and EBV• Ceruloplasmin level (Wilson disease)• Head CT if grade IV encephalopathy present (coma)• Temperature +++ When to Admit + • Any patient with acute hepatic injury, ICU for fulminant cases +++ When to Refer + • Transplantation center whenever encephalopathy develops +++ Surgery + • Liver transplantation• Ventriculostomy for grade IV encephalopathy +++ Indications + • Fulminant or subfulminant failure unresponsive to medical management +++ Contraindications + • Medical comorbidities precluding transplantation, active malignancy +++ Medications + • N-acetylcysteine• Minimizing hypoglycemia• Broad-spectrum antibiotics for any fever (avoid aminoglycosides)• Fresh frozen plasma for planned invasive interventions• Mannitol for elevated intracranial pressure• Vasopressor support for hypotension• Mechanical ventilation for grade IV encephalopathy +++ Treatment Monitoring + • Frequent neurologic exams and head CT scans when indicated• Liver function tests• PT +++ Complications + • Primary nonfunction• Rejection• Biliary leak or stricture• hemorrhage• Hepatic artery thrombosis +++ Prognosis + • 60-70% 5-year survival following liver transplant• All patients recover from acute illness in absence of encephalopathy• Greater than 50% recovery for patients with grade III encephalopathy• Overall survival correlated with grade of encephalopathy• Rapid onset associated with more favorable prognosis• Associated sepsis, acidosis, age < 2 or > 40 years, renal failure, PT > 50 all associated with worse prognosis +++ References ++Schiodt FV, Lee WM. Fulminant liver disease. ... Your Access profile is currently affiliated with [InstitutionA] and is in the process of switching affiliations to [InstitutionB]. Please select how you would like to proceed. Keep the current affiliation with [InstitutionA] and continue with the Access profile sign in process Switch affiliation to [InstitutionB] and continue with the Access profile sign in process Get Free Access Through Your Institution Learn how to see if your library subscribes to McGraw Hill Medical products. Subscribe: Institutional or Individual Sign In Error: Incorrect UserName or Password Username Error: Please enter User Name Password Error: Please enter Password Sign in Forgot Password? Forgot Username? Sign in via OpenAthens Sign in via Shibboleth You already have access! Please proceed to your institution's subscription. Create a free profile for additional features.